Neratinib Recruiting Phase 2 Trials for Advanced Breast Cancer Other

IndicationsStatusPurposePhase
RecruitingOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT03182634The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial